Cardiogenic brain embolism: The second report of the cerebral embolism task force

Archives of Neurology

Volumn 46, Issue 7, 1989, Pages 727-743

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN EMBOLISM; CARDIOMYOPATHY; COMPLICATION; ENDOCARDITIS; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE ANEURYSM; HEART VALVE PROSTHESIS; HUMAN; MITRAL VALVE PROLAPSE; PARADOXICAL EMBOLISM; PRIORITY JOURNAL; REVIEW;

ATRIAL FIBRILLATION; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; CORONARY THROMBOSIS; EMBOLISM; ENDOCARDITIS; HUMAN; INTRACRANIAL EMBOLISM AND THROMBOSIS; ISCHEMIC ATTACK, TRANSIENT; MITRAL VALVE PROLAPSE; MYOCARDIAL INFARCTION;

EID: 0024380805     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1989.00520430021013     Document Type: Article

References (303)

1. Cerebral Embolism Task Force. Cardiogenic brain embolism.American Medical Association. 1986;43:71-84.
2. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1988;19:547-554.
3. Gross CR, Shinar D, Mohr JP, et al. Interobserver agreement in the diagnosis of stroke type.American Medical Association. 1986;43:893-898.
4. Bogousslavsky J, Hachinski VC, Boughner DR, Fox AJ, Vinuela F, Barnett HJM. Cardiac and arterial lesions in carotid transient ischemic attacks.American Medical Association. 1986;43:223-228.
5. Rem JA, Hachinski VC, Boughner DR, Barnett HJM. Value of cardiac monitoring and echocardiography in TIA and stroke patients.
6. Olsen TS, Skriver EB, Herning M. Cause of cerebral infarction in the carotid territory: its relation to the size and the location of the infarct and to the underlying vascular lesion. Stroke. 1985;16:459-466.
7. Bogousslavsky J, Melle GV, Regli F. The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke. 1988;19:1083-1092.
8. Ferro JM, Crespo M. Young adult stroke: neuropsychological dysfunction and recovery. Stroke. 1988;19:982-986.
9. Gagliardi R, Benvenuti L, Frosini F, Ammannati F, Barletta GA, Fantini F. Frequency of echocardiographic abnormalities in patients with ischemia of the carotid territory—a preliminary report. Stroke. 1985;16:118-120.
10. Caplan LR, Hier DB, D'Cruz I. Cerebral embolism in the Michael Reese Stroke Registry. Stroke. 1983;14:530-537.
11. Ramirez-Lassepas M, Cipolle RJ, Bjork RJ, et al. Can embolic stroke be diagnosed on the basis of neurologic clinical criteria?American Medical Association. 1987;44:87-89.
12. Good DC, Frank S, Verhulst S, Sharma B. Cardiac abnormalities in stroke patients with negative arteriograms. Stroke. 1986;17:6-11.
13. Monreal M, Callejas JM, Maxtorell A, Vallev, Larrouse E. Extracranial carotid artery disease in patients with arterial limb embolism. Stroke. 1989;20:127.
14. Fogelholm R, Melin J. Echocardiography in ischaemic cerebrovascular disease. Br Med J Clin Res. 1987;295:305-306.
15. Fisher CM. The posterior cerebral artery syndrome. Can J Neurol Sci. 1986;13:232-239.
16. Pessin MS, Lathi ES, Cohen MB, Kwan ES, Hedges TR, Caplan LR. Clinical features and mechanism of occipital infarction. Ann Neurol. 1987;21:290-299.
17. Ott BR, Zamini A, Kleefield J, Funkenstein HH. The clinical spectrum of hemorrhagic infarction. Stroke. 1986;17:630-637.
18. Jackson AC, Boughner DR, Barnett HJM. Mitral valve prolapse and cerebral ischemic events in young patients. Neurology. 1984;34:784-787.
19. Hart RG, Foster JW, Luther MF. Bacterial endocarditis, stroke, and brain hemorrhage. Stroke. 1987;18:298. Abstract.
20. Kapila A, Hart RG. Calcific cerebral emboli and aortic stenosis: detection by computed tomography. Stroke. 1986;17;619-621.
21. Harrison MJG, Marshall J. Wernicke aphasia and cardiac embolism. J Neurol Neurosurg Psychiatry. 1987;50:938-939.
22. Knepper LE, Biller J, Tranel D, Adams HP. Cerebral emboli as a common cause of Wernicke's aphasia. Ann Neurol. 1988;24:157. Abstract.
23. Legatt AD, Rubin MJ, Kaplan LR, Healton EB, Brust JCM. Global aphasia without hemiparesis: multiple etiologies. Neurology. 1987;37:201-205.
24. Weisberg LA. Nonseptic cardiogenic cerebral embolic stroke: clinical-CT correlations. Neurology. 1985;35:896-899.
25. Santamaria J, Graus F, Rubio F, Aribizu T, Peres J. Cerebral infarction of the basal ganglia due to embolism from the heart. Stroke. 1983;14:911-914.
26. Bogousslavsky J, Hachinski VC, Boughner DR, Fox AJ, Vinuela F, Barnett HJM. Clinical predictors of cardiac and arterial lesions in carotid transient ischemic attacks.American Medical Association. 1986;43:229-233.
27. Fisher CM, Adams RD. Observations on brain embolism with special reference to hemorrhagic infarction. In: Furlan AJ, ed. The Heart and Stroke: Exploring Mutual Cardiovascular Issues. New York, NY: Springer-Verlag NY Inc; 1987:17-36.
28. Horning CR, Dorndorf W, Agnoli AL. Hemorrhagic cerebral infarction: a prospective study. Stroke. 1986;17:179-185.
29. Lodder J, Krijne-Kubat B, Broekman J. Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death. Stroke. 1986;17:626-629.
30. Hart RG, Easton JD. Hemorrhagic infarcts. Stroke. 1986;17:586-589.
31. Beattie BA, Struck L, Stanford W, et al. Two-dimensional echocardiography and ultrafast cardiac computed tomography for detection of intracardiac thrombi in cerebral ischemia. Ann Neurol. 1988;24:155. Abstract.
32. Masuda Y, Morooka N, Yoshida H, Watanabe S, Inagaki Y. Noninvasive diagnosis of thrombus in the heart and large vessels: usefulness of two dimensional echocardiography and x-ray CT. Jpn Circ J. 1984;48:83-89.
33. Helgason CM, Chomka EV, Rich S, Brundage BN. Ultrafast cardiac CT scanning in stroke. Stroke. 1987;18:283. Abstract.
34. Foster CJ, Sekiya T, Love HG, Brownless WC, Griffin JF, Isherwood I. Identification of intracardiac thrombus: comparison of computed tomography and cross-sectional echocardiography. Br J Radiol. 1987;60:327-331.
35. Goldstein JA, Schiller NB, Lipton MJ, Ports TA, Brundage BH. Evaluation of left ventricular thrombi by contrast-enhanced computed tomography and two-dimensional echocardiography. Am J Cardiol. 1986;57:757-760.
36. Gomes AS, Lois JF, Child JS, Brown K, Batra P. Cardiac tumors and thrombus: evaluation with MR imaging. AJR. 1987;149:895-899.
37. Fletcher DB, Jacobstein MD, Nelson AD, Riemenschneider TA, Alfidi RJ. Gated magnetic resonance imaging of congenital cardiac malformations. Radiology. 1985;150:137-140.
38. Seward JB, Khandheria BK, Oh JK, et al. Transesophageal echocardiography: technique, anatomic correlations, implementation, and clinical applications. Mayo Clin Proc. 1988;63:649-660.
39. Zenker G, Erbel R, Kramer G, et al. Transesophageal two-dimensional echocardiography in young patients with cerebral ischemic events. Stroke. 1988;19:345-348.
40. Aschenberg W, Schluter M, Kremer P, Schroder E, Siglow V, Bleifeld W. Transesophageal two-dimensional echocardiography for detection of left atrial appendage thrombus. J Am Coll Cardiol. 1986;7:163-166.
41. Kessler C, Henningsen H, Reuther R, Kimming B, Rosch M. Identification of intracardiac thrombi in stroke patients with indium-111 platelet scintigraphy. Stroke. 1987;18:63-67.
42. Come PC, Riley MF, Bivas NK. Roles of echocardiography and arrhythmia monitoring in the evaluation of patients with suspected systemic embolism. Ann Neurol. 1983;13:527-531.
43. Robbins JA, Sagar KB, French M, Smith PJ. Influence of echocardiography on management of patients with systemic emboli. Stroke. 1983;14:546-549.
44. Todnem K, Vik-Mo H. Cerebral ischemic attacks as a complication of heart disease: the value of echocardiography. Acta Neurol Scand. 1986;74:323-327.
45. Nishide M, Irino T, Gotoh M, Naka M, Tsuji K. Cardiac abnormalities in ischemic cerebrovascular disease studied by two-dimensional echocardiography. Stroke. 1983;14:541-545.
46. Biller J, Johnson MR, Adams HP, Kerber RE, Toffol GJ, Butler MJ. Echocardiographic evaluation of young adults with nonhemorrhagic cerebral infarction. Stroke. 1986;17:608-612.
47. Irwin JA, Heinsimer JA, Hammett LA, Hlatky MA. A new clinical algorithm for the use of echocardiography in patients with ischemic neurologic syndromes. Circulation. 1986;74(suppl 2):153.
48. Koudstaal PJ, van Gijn J, Klootwijk APJ, van der Meche FGA, Kappelle LJ. Holter monitoring in patients with transient and focal ischemic attacks of the brain. Stroke. 1986;17:192-195.
49. Sherman DG, Hart RG, Shi F. Heart-brain interactions: neurocardiology comes of age. Mayo Clin Proc. 1987;62:1158-1160.
50. Shuaib A, Hachinski VC, Oczkowski WJ. Transient ischemic attacks and normal cerebral angiograms: a follow-up study. Stroke. 1988;19:1223-1228.
51. Friedman GD, Loveland DB, Ehrlich SP. Relationship of stroke to other cardiovascular disease. Circulation. 1968;38:533-541.
52. Fisher CM. Treatment of chronic atrial fibrillation. Lancet. 1972;1:1284.
53. Yamanouchi H, Nagura H, Ohkawa Y, et al. Anticoagulant therapy in recurrent cerebral embolism: a retrospective study in nonvalvular atrial fibrillation. J Neurol. 1988;235:407-410.
54. Kitchens JM, Flegel KM. Atrial fibrillation, stroke and anticoagulation: what is to be done? J Gen Intern Med. 1986;1:126-130.
55. Starkey I, Warlow CP. The secondary prevention of stroke in patients with atrial fibrillation.American Medical Association. 1986;43:66-68.
56. Sherman DG, Hart RG, Easton JD. The secondary prevention of stroke in patients with atrial fibrillation.American Medical Association. 1986;43:68-70.
57. Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke. 1988;19:961-965.
58. Harrison MJG, Marshall J. Atrial fibrillation, TIAs, and completed strokes. Stroke. 1984;15:441-442.
59. Kuramoto K, Matsushita S, Yamanouchi H. Atrial fibrillation as a cause of myocardial and cerebral infarctions. Jpn Circ J. 1984;48:67-74.
60. Norrving B, Nilsson B. Cerebral embolism of cardiac origin: the limited possibilities of secondary prevention. Acta Neurol Scand. 1986;73:520. Abstract.
61. Kelley RE, Berger JR, Alter M, Kovacs AG. Cerebral ischemia and atrial fibrillation: prospective study. Neurology. 1984;34:1285-1291.
62. Flegel KM, Shipley MJ, Rose G. Risk of stroke in nonrheumatic atrial fibrillation. Lancet. 1987;1:526-529.
63. Tanaka H, Hayashi M, Date C, et al. Epidemiologic studies of stroke in Shibata, a Japanese provincial city: preliminary report on risk factors for cerebral infarction. Stroke. 1985;16:775-780.
64. Onundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson Th. Chronic atrial fibrillation: epidemiologic features and 14 year follow-up: a case-control study. Eur Heart J. 1987;8:521-527.
65. Wolf PA, Dawber TR, Thomas HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology. 1978;28:973-977.
66. Davis PH, Dambrosia JM, Schoenberg BS, et al. Risk factors for ischemic stroke: a prospective study in Rochester, Minnesota. Ann Neurol. 1987;22:319-327.
67. Kopecky SL, Gerah BJ, McGoon MD, et al. The natural history of lone atrial fibrillation. N Engl J Med. 1987;317:669-674.
68. Close JB, Evans DW, Bailey SM. Persistent lone atrial fibrillation: its prognosis after clinical diagnosis. J R Coll Gen Pract. 1979;29:547-549.
69. Roy D, Marchand E, Gagne P, Chabot M, Cartier R. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J. 1986;112:1139-1143.
70. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. JAMA. 1985;254:3449-3453.
71. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med. 1987;147:1561-1564.
72. Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke. 1986;17:622-626.
73. Fortin AH, Isner JM. Should patients with paroxysmal atrial fibrillation receive prophylactic anticoagulants? J Am Coll Cardiol. 1983;1:704.
74. Fisher CM. Reducing risks of cerebral embolism. Geriatrics. 1979;34:59-66.
75. Petersen P, Godtfredsen J, Boysen G. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet. 1989;1:175-178.
76. Fisher M, Kase CS, Stelle B, Mills RM. Ischemic stroke after cardiac pacemaker implantation in sick sinus syndrome. Stroke. 1988;19:712-715.
77. Rosenquist M, Brandt J, Schuller A. Atrial versus ventricular pacing in sinus node disease: a treatment comparison study. Am Heart J. 1986;111:292-297.
78. Yamauchi K, Furui H, Taniguchi N, Sotobata I. Plasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation. Jpn Heart J. 1986;27:481-487.
79. Godtfredsen J, Egeblad H, Berning J. Echocardiography in lone atrial fibrillation. Acta Med Scand. 1983;213:111-113.
80. Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke. 1988;19:15-18.
81. Presti CF, Hart RG. Thyrotoxicosis, atrial fibrillation, and embolism, revisited. Am Heart J. 1989;117:976-977.
82. Yuen RWM, Gutteridge DH, Thompson PL, Robinson JS. Embolism in thyrotoxic atrial fibrillation. Med J Aust. 1979;1:630-631.
83. Hurley DM, Hunter AN, Hewett MJ, Stockigt JR. Atrial fibrillation and arterial embolism in hyperthyroidism. Aust NZ J Med. 1981;11:391-393.
84. Bar-Sela S, Ehrenfeld M, Eliakim M. Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med. 1981;141:1191-1192.
85. Bridgers SL, Ezekowitz M, Ho TY. Stroke prevention in nonvalvular atrial fibrillation: initiation of a VA Cooperative Study. Neurology. 1988;38(suppl 1):295. Abstract.
86. Feinberg WM, Seeger JF, Carmody RF, Hart RG, Anderson DC, Miller VT. Asymptomatic cerebral infarction in patients with atrial fibrillation. Circulation. 1988;78:600. Abstract.
87. Petersen P, Madsen EB, Brun B, Pederson F, Boysen G. Silent cerebral infarction in atrial fibrillation. Stroke. 1987;18:1098-1100.
88. Kempster PA, Gerraty RP, Gates PC. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. Stroke. 1988;19:955-958.
89. Lodder J, Dennis MS, Van Raak L, Jones LN, Warlow CP. Cooperative study on the value of long-term anticoagulation in stroke patients with nonrheumatic atrial fibrillation. Br Med J Clin Res. 1988;296:1435-1438.
90. Britton M, Gustafson C. Nonrheumatic atrial fibrillation as a risk factor for stroke. Stroke. 1985;16:182-188.
91. Tegeler CH, Hart RG, Sherman DG, Quiroga ES, Easton JD. Atrial Fibrillation-Stroke Study. Stroke. 1986;17:131. Abstract.
92. Weinberger J, Rothlauf EB, Matarese EL, Halpern JL. Noninvasive evaluation of the extracranial carotid arteries in patients with cerebrovascular events and atrial fibrillation. Arch Intern Med. 1988;148:1785-1788.
93. Wiener I. Clinical and echocardiographic correlates of systemic embolization in nonrheumatic atrial fibrillation. Am J Cardiol. 1987;59:177.
94. Hart RG, Easton JD, Sherman DG. Duration of nonvalvular atrial fibrillation and stroke. Stroke. 1983;14:827.
95. Wolf PA, Kannel WB, McGee DL. Duration of atrial fibrillation and imminence of stroke: the Framingham Study. Stroke. 1983;14:664-667.
96. Ruocco NA, Most AS. Clinical and echocardiographic risk factors for systemic embolization in patients with atrial fibrillation in the absence of mitral stenosis. J Am Coll Cardiol. 1986;7:165. Abstract.
97. Tegeler CH, Hart RG. Atrial size, atrial fibrillation and stroke. Ann Neurol. 1987;21:315-316.
98. Aronow WS, Gutstein H, Hsieh FY. Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol. 1989;63:366-367.
99. Walker MD. Atrial fibrillation and antithrombotic prophylaxis: a prospective metaanalysis. Lancet. 1989;1:325-326.
100. Johannessen KA, Nordrehaug JE, von der Lippe G, Vollset SE. Risk factors for embolization in patients with left ventricular thrombi and acute myocardial infarction. Br Heart J. 1988;60:104-110.
101. International Collaborative Study Group. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med. 1984;310:9-15.
102. Puletti M, Cusmano E, Testa MG, Borgia C, Fanari F, Curone M. Incidence of systemic thromboembolic lesions in acute myocardial infarction. Clin Cardiol. 1986;3:331-333.
103. Puletti M, Morocutti C, Borgia C, et al. Acute myocardial infarction and brain. Ital J Neurol Sci. 1987;8:245-248.
104. Haugland JM, Asinger RW, Mikell FL, Elsperger J, Hodges M. Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography. Circulation. 1984;70:588-594.
105. Johannessen KA, Nordehaug JE, von der Lippe G. Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction. Br Heart J. 1984;51:553-556.
106. Komrad MS, Coffey E, Coffey KS, McKinnis R, Massey EW, Califf RM. Myocardial infarction and stroke. Neurology. 1984;34:1403-1409.
107. Nordrehaug JE, Johannessen KA, Von der Lippe G. Usefulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial infarction. Am J Cardiol. 1985;55:1491-1493.
108. Arvan S, Boscha K. Prophylactic anticoagulation for left ventricular thrombi after acute myocardial infarction: a prospective randomized trial. Am Heart J. 1987;113:688-693.
109. Domenicucci S, Bellotti P, Chiarella F, Lupi G, Vecchio C. Spontaneous morphologic changes in left ventricular thrombi: prospective two-dimensional echocardiographic study. Circulation. 1987;75:737-743.
110. Gueret P, Dubourg O, Ferrier A, Farcot JC, Rigaud M, Bourdarias JP. Effects of full-dose heparin on the development of left ventricular thrombosis in acute transmural myocardial infarction. J Am Coll Cardiol. 1986;8:419-426.
111. Weinreich DJ, Burke JF, Pauletto FJ. Left ventricular mural thrombi complicating acute myocardial infarction: long-term follow-up with serial echocardiography. Ann Intern Med. 1984;100:789-794.
112. Kaplan K. Prophylactic anticoagulation following acute myocardial infarction. Arch Intern Med. 1986;146:593-597.
113. Kinney EL. The significance of left ventricular thrombi in patients with coronary heart disease: a retrospective analysis of pooled data. Am Heart J. 1985;109:191-194.
114. Ezekowitz MD. Acute infarction, left ventricular thrombus and systemic embolization: an approach to management. J Am Coll Cardiol. 1985;5:1281-1282.
115. Chesebro JH, Ezekowitz MD, Badimon L, Fuster V. Intracardiac thrombi and systemic thromboembolism: detection, incidence and treatment. Annu Rev Med. 1985;36:579-605.
116. Meltzer RS, Visser CE, Fuster V. Intracardiac thrombi and systemic embolization. Ann Intern Med. 1986;104:689-698.
117. Fuster V, Halperin JL. Left ventricular thrombi and cerebral embolism. N Engl J Med. 1989;320:392-394.
118. Starling MR, Crawford MH, Sorensen SG, Grover FL. Comparative value of invasive and noninvasive techniques for identifying left ventricular mural thrombi. Am Heart J. 1983;106:1143-1149.
119. Visser CA, Kan G, David GK, Lie KI, Durrer D. Two-dimensional echocardiography in the diagnosis of left ventricular thrombus: prospective study of 67 patients with anatomic validation. Chest. 1983;83:228-232.
120. Visser CA, Kan G, Meltzer RS, Lie KI, Durrer D. Long-term follow-up of left ventricular thrombus after acute myocardial infarction. Chest. 1984;86:532-536.
121. Keating EC, Gross SA, Schlamowitz RA, Glassman J, Mazur JH, Miller D. Mural thrombi in myocardial infarction: prospective evaluation by two-dimensional echocardiography. Am J Med. 1983;74:989-995.
122. Asinger RW, Mikell FL, Elsperger J, Hodges M. Incidence of left ventricular thrombosis after acute transmural myocardial infarction. N Engl J Med. 1981;305:297-302.
123. Friedman MJ, Carlson K, Marcus FI, Woulfenden JM. Clinical correlations in patients with acute myocardial infarction and left ventricular thrombus detected by two-dimensional echocardiography. Am J Med. 1982;72:894-898.
124. Bhatnager SK, Hudak A, Al-Yusuf AR. Left ventricular thrombosis, wall motion abnormalities, and blood viscosity changes after first transmural anterior myocardial infarction. Chest. 1985;88:40-44.
125. Johannessen KA, Stratton JR, Taulow E, Osterud B, von der Lippe G. Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction. Am J Cardiol. 1989;63:101-102.
126. Spirito P, Bellotti P, Chiarella F, Domenicucci S, Sementa A, Vecchio C. Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two-dimensional echocardiographic study. Circulation. 1985;72:774-778.
127. Visser CA, Kan G, Meltzer RS, Dunning AJ, Roelandt J. Embolic potential of left ventricular thrombus after myocardial infarction: a two-dimensional echocardiographic study of 119 patients. J Am Coll Cardiol. 1985;5:1276-1280.
128. Tramarin R, Pozzoli M, Febo O, et al. Twodimensional echocardiographic assessment of anticoagulant therapy in left ventricular thrombosis early after acute myocardial infarction. EurHeart J. 1986;7:482-492.
129. Arvan S. Persistent intracardiac thrombi and systemic embolization despite anticoagulant therapy. Am Heart J. 1985;109:178.
130. Hwang MH, Pacold I, Loeb HS. Acute anterior myocardial infarction complicated by mural thrombus and peripheral thromboembolism despite anticoagulation. Cathet Cardiovasc Diagn. 1985;11:417-422.
131. Kremer P, Fiebig R, Tilsner V, Bleifeld W, Mathey DG. Lysis of left ventricular thrombi with urokinase. Circulation. 1985;72:112-118.
132. Davis MJE, Ireland MA. Effect of early anticoagulation on the frequency of left ventricular thrombi after anterior wall acute myocardial infarction. Am J Cardiol. 1986;57:1244-1247.
133. Turpie AGG, Robinson JG, Doyle DJ, et al. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med. 1989;320:352-357.
134. Johannessen KA, Nordrehaug JE, von der Lippe G. Increased occurrence of left ventricular thrombi during early treatment with timolol in patients with acute myocardial infarction. Circulation. 1987;75:151-155.
135. Norwegian Multicenter Group. Timololinduced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801-805.
136. Johannessen KA. Peripheral emboli from left ventricular thrombi of different echocardiographic appearance in acute myocardial infarction. Arch Intern Med. 1987;147:641-644.
137. Eigler N, Maurer G, Shah PK. Effect of early systemic thrombolytic therapy on left ventricular mural thrombus formation in acute anterior myocardial infarction. Am J Cardiol. 1984;54:261-264.
138. Sharma B, Caravalho A, Wyeth R, Franciosa JA. Left ventricular thrombi diagnosed by echocardiography in patients with acute myocardial infarction treated with intracoronary streptokinase followed by intravenous heparin. Am J Cardiol. 1985;56:422-426.
139. Stratton JR, Speck SM, Caldwell JH, et al. Late effects of intracoronary streptokinase on regional wall motion, ventricular aneurysm and left ventricular thrombus in myocardial infarction: results from the Western Washington Randomized Trial. J Am Coll Cardiol. 1985;5:1023-1028.
140. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Longterm effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI Study. Lancet. 1987;2:871-875.
141. Natarajan D, Hotchandani RK, Nigam PD. Reduced incidence of left ventricular thrombi with intravenous streptokinase in acute anterior myocardial infarction: prospective evaluation by cross-sectional echocardiography. Int J Cardiol. 1988;20:201-207.
142. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
143. Berger EE, Most AS, Gewirtz H. Resolution of extensive left ventricular dyskinesis three months after acute myocardial infarction. Am Heart J. 1987;114:1508-1510.
144. Asinger RW, Mikell FL, Elsperger J, et al. Serial changes in left ventricular wall motion by two-dimensional echocardiography following anterior myocardial infarction. Am Heart J. 1988;226:50-58.
145. Lepeyre AC, Steele PM, Kazmier FJ, Chesebro JH, Vlietstra RE, Fuster V. Systemic embolism in chronic left ventricular aneurysm: incidence and the role of anticoagulation. J Am Coll Cardiol. 1985;6:534-538.
146. Stratton JR, Resnick AD. Increased embolic risk in patients with left ventricular thrombi. Circulation. 1987;75:1004-1011.
147. Lloret RL, Cortada X, Bradford J, Metz MN, Kinney EL. Classification of left ventricular thrombi by their history of systemic embolization using pattern recognition of two-dimensional echocardiograms. Am Heart J. 1985;110:761-765.
148. Stratton JR, Ritchie JL. The effects of antithrombotic drugs in patients with left ventricular thrombi: assessment with indium-111 platelet imaging and two-dimensional echocardiography. Circulation. 1984;69:561-569.
149. Kyrie PA, Korninger C, Gossinger H, et al. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost. 1985;54:521-523.
150. Verma AK, Alam M, Rossman HS, Brymer J, Keith F. Systemic embolization from thrombus in normal left ventricles. Chest. 1988;93:441-442.
151. Case records of the Massachusetts General Hospital. N Engl J Med. 1988;318:970-981. Case 15-1988.
152. Botker HE, Rasmussen OB. Recurrent cerebral embolism in cardiac amyloidosis. Int J Cardiol. 1986;13:81-83.
153. Oliveira JSM, Correa de Araujo RR, Navarro MA, Muccillo G. Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol. 1983;52:147-151.
154. Schmaier AH, Denenberg B. Left ventricular thrombus with normal left ventricular function and hyperaggreable platelets in a patient with polycystic disease of multiple organs. Am J Med Sci. 1984;288:223-227.
155. DeGroat TS, Parameswaran R, Popper P, Kotler MN. Left ventricular thrombi in association with normal left ventricular wall motion in patients with malignancy. Am J Cardiol. 1985;56:827-828.
156. Toto AS, Parameswaran R, Kotler MN, Parry W. Rapid development of left ventricular thrombus in a patient with myeloproliferative disorder. Am Heart J. 1987;114:436-437.
157. Stoddard MF, Pearson AC, Kanter KR, Labovitz AJ. Left ventricular thrombus with normal left ventricular wall motion in a patient with myelofibrosis. Am Heart J. 1989;117:966-968.
158. Takamoto T, Kim D, Urie PM, et al. Comparative recognition of left ventricular thrombi by echocardiography and cineangiography. Br Heart J. 1985;53:36-42.
159. Tobin R, Slutsky RA, Higgins CB. Serial echocardiograms in patients with congestive cardiomyopathies: lack of evidence for thrombus formation. Clin Cardiol. 1984;7:99-101.
160. Gottdiener JS, Gay JA, VanVoorhees L, DiBianco R, Fletcher RD. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by two-dimensional echocardiography. Am J Cardiol. 1983;52:1281-1285.
161. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenberg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47:525-531.
162. Adams PC, Cohen M, Chesebro JH, Fuster V. Thrombosis and embolism from cardiac chambers and infected valves. J Am Coll Cardiol. 1986;8:76B-87B.
163. Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol. 1985;6:1126-1131.
164. Julian DG, Szekely P. Peripartum cardiomyopathy. Prog Cardiovasc Dis. 1985;27:223-240.
165. Gottdiener JS, Maron BJ, Schooley RT, Harley JB, Roberts WC, Fauci AS. Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilia syndrome: anatomic basis of mitral regurgitation and peripheral embolization. Circulation. 1983;67:572-578.
166. Heiskell Ca, Conn JC. Aortoarterial emboli. Am J Surg. 1976;132:4-7.
167. Shenoy MM, Vijaykumar PM, Friedman SA, Greif E. Atrial septal aneurysm associated with systemic embolism and interatrial right-toleft shunt. Arch Intern Med. 1987;147:605-606.
168. Gorelick PB, Rusinowitz MS, Tiku M, McDonald LW, Robbins L. Embolic stroke complicating systemic lupus erythematosus.American Medical Association. 1985;42:813-815.
169. Dugani BV, Higginson LAJ, Beanlands DS, Akyurekli Y. Recurrent systemic emboli following myocardial contusion. Am Heart J. 1984;108:1534-1537.
170. Huycke EC, Robinowitz M, Cohen IS, et al. Granulomatous endocarditis with systemic embolism in Behçet's disease. Ann Intern Med. 1985;102:791-793.
171. Schachter S, Freeman R. TIA and Adriamycin cardiomyopathy. Neurology. 1982;32:1380-1381.
172. Homans DC. Peripartum cardiomyopathy. N Engl J Med. 1985;312:1432-1437.
173. Fox IS, Spence AM, Wheelis RF, Healey LA. Cerebral embolism in Libman-Sacks endocarditis. Neurology. 1980;30:487-491.
174. Biller J, Ionasescu V, Zellweger H, Adams HP, Schultz D. Incidence of cerebral infarction in inherited neuromuscular conditions. Stroke. 1987;18:805-807.
175. Nespeca MP, Townsend JJ. Multiple cerebral emboli in a young man. West J Med. 1987;146:589-595.
176. Wolf PA, Sila CA. Cerebral ischemia with mitral valve prolapse. Am Heart J. 1987;113:1308-1315.
177. Kogure S, Yamamoto Y, Tomono S, Hasegawa A, Suzuki T, Murata K. High risk of systemic embolism in hypertrophic cardiomyopathy. Jpn Heart J. 1986;27:475-480.
178. Lin CS, Schwartz IS, Chapman I. Calcification of the mitral annulus fibrosus with systemic embolization. Arch Pathol Lab Med. 1987;111:411-414.
179. Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic endocarditis: a review. Am Heart J. 1987;113:773-784.
180. Lechat P, Mas JL, Lescault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148-1152.
181. Jackson AC. Neurologic disorders associated with mitral valve prolapse. Can J Neurol Sci. 1986;13:15-20.
182. Adams HP, Butler MJ, Biller J, Toffal GJ. Nonhemorrhagic cerebral infarction in young adults.American Medical Association. 1986;43:793-796.
183. Hachinski V, Norris JW. The Acute Stroke. Philadelphia, Pa: FA Davis Co Publishers; 1985:141-142.
184. Egeblad H, Sorensen PS. Prevalence of mitral valve prolapse in younger patients with cerebral ischaemic attack: a blinded controlled study. Acta Med Scand. 1984;216:385-391.
185. Nencini P, Inzitari D, Baraffi MC, et al. Incidence of stroke in young adults in Florence, Italy. Stroke. 1988;19:977-981.
186. Rothrock JF, Dittrich HC, Fleck P, Blacky AR, Watson J. Mitral valve prolapse and ischemic stroke in the young. Circulation. 1988;78:601.
187. Kouvaras G, Bacoulas G. Association of mitral leaflet prolapse with cerebral ischemic events in the young and early middle-aged patient. Q J Med. 1985;55:387-392.
188. Bogousslavsky J, Regli F. Ischemic stroke in adults younger than 30 years of age.American Medical Association. 1987;44:479-482.
189. Wann LS, Gross CM, Wakefield RJ, Kalbfleisch JH. Diagnostic precision of echocardiography in mitral valve prolapse. Am Heart J. 1985;109:803-808.
190. Levine RA, Stathogiannis E, Newell JB, Harrigan P, Weyman AE. Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol. 1988;11:1010-1019.
191. Nishimura RA, McGoon MD, Shub C, Miller FA, Ilstrup DM, Tajik AJ. Echocardiographically documented mitral valve prolapse: long-term follow-up of 237 patients. N Engl J Med. 1985;313:1305-1309.
192. Perloff JK, Child JS, Edwards JE. New guidelines for the clinical diagnosis of mitral valve prolapse. Am J Cardiol. 1986;57:1124-1129.
193. Devereux RB, Hawkins I, Kramer-Fox R, et al. Complications of mitral valve prolapse. Am J Med. 1986;81:751-758.
194. Baddour LM, Bisno AL. Infective endocarditis complicating mitral valve prolapse: epidemiologic, clinical and microbiologic aspects. Rev Infect Dis. 1986;117-136.
195. Zenker G, Bone G, Ladurner G, Lechner H. The myxomatous mitral valve. Eur Neurol. 1985;24:82-84.
196. Barletta GA, Gagliardi R, Benvenuti L, Fantini F. Cerebral ischemic attacks as a complication of aortic and mitral valve prolapse. Stroke. 1985;16:219-223.
197. Kelly RE, Pina I, Lee SC. Cerebral ischemia and mitral valve prolapse: case-control study of associated factors. Stroke. 1988;19:443-446.
198. Egeblad H, Hesse B. Mitral valve prolapse with mobile polypoid cul-de-sac thrombus and embolism to brain and lower extremity. Am Heart J. 1987;114:648-650.
199. Busch EH, Snyder DW, Barron RE. Embolic stroke in a woman with mitral valve prolapse who used oral contraceptives. Chest. 1986;90:454-455.
200. Wallis DE, Godwin J. Mitral valve prolapse, cerebral ischemia, and protein S deficiency. Am J Med. 1988;84:974.
201. Elam MB, Viar MJ, Ratts TE, Chesney CM. Mitral valve prolapse in women with oral contraceptive-related cerebrovascular insufficiency. Arch Intern Med. 1986;146:73-77.
202. Bisset GS, Schwartz DC, Meyer RA, James FW, Kaplan S. Clinical spectrum and long-term follow-up of isolated mitral valve prolapse in 119 children. Circulation. 1980;62:423-429.
203. Duren DR, Becker AE, Dunning AJ. Longterm follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study. J Am Coll Cardiol. 1988;11:42-47.
204. Bloomfield P, Kitchin AH, Wheatley DJ, Walbaum PR, Lutz W, Miller HC. A prospective evaluation of the Bjork-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses. Circulation. 1986;73:1213-1222.
205. Olesen KH, Rygg IH, Wennevold A, Nyboe J. Long-term follow-up in 185 patients after mitral valve replacement with the Lillehei-Kaster prosthesis: overall results and prosthesisrelated complications. Eur Heart J. 1987;8:680-688.
206. Kuntze CE, Ebels T, Eijgelaar A, van der Heide JNH. Rates of thromboembolism with three different mechanical heart valve prostheses: randomised study. Lancet. 1989;1:514-517.
207. Hartz RS, LoCicero J, Kucich V, et al. Comparative study of warfarin versus antiplatelet therapy in patients with St Jude Medical valve in the aortic position. J Thorac Cardiovasc Surg. 1986;92:684-690.
208. Burckhardt D, Striebel D, Vogt S, et al. Heart valve replacement with St Jude Medical Valve prosthesis. Circulation. 1988;78(suppl 1):118-123.
209. Butchart EG, Lewis PA, Grunkemeier GL, Kulatilake N, Breckenridge IM. Low risk of thrombosis and serious embolic events despite low-intensity anticoagulation: experience with 1,004 Medtronic Hall valves. Circulation. 1988;78(suppl 1):166-177.
210. Arom KV, Nicoloff DM, Kersten TE, Lindsay WG, Northrup WF. St Jude Medical prosthesis: valve-related deaths and complications. Ann Thorac Surg. 1987;43:591-598.
211. Edmunds LH. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg. 1987;44:430-445.
212. Chesebro JH, Adams PC, Fuster V. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves. J Am Coll Cardiol. 1986;8:41B-56B.
213. Kopf GS, Hammond GL, Geha AS, Elefteriades J, Hashim SW. Long-term performance of the St Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin. Circulation. 1987;76(suppl 2):132-136.
214. Turpie AGG, Gunstensen J, Hirsh J, Nelson H, Gent M. Randomized comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Lancet. 1988;1:1242-1245.
215. Mok CK, Boey J, Wang R, et al. Warfarin versus dipyridamole-aspirin and pentoxifyllineaspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. Circulation. 1985;72:1059-1063.
216. El Makhlouf A, Friedli B, Oberhansli I, Rouge JC, Faidutti B. Prosthetic heart valve replacement in children. J Thorac Cardiovasc Surg. 1987;93:80-85.
217. Ilbawi MN, Lockhart CG, Idriss FS, et al. Experience with St Jude Medical valve prosthesis in children. J Thorac Cardiovasc Surg. 1987;83:73-39.
218. Verrier ED, Tranbaugh RF, Soifer SJ, Yee ES, Turley K, Ebert PA. Aspirin anticoagulation in children with mechanical aortic valves. J Thorac Cardiovasc Surg. 1986;92:1013-1020.
219. McGrath LB, Gonzalez-Levin L, Eldredge WJ, et al. Thromboembolic and other events following valve replacement in a pediatric population treated with antiplatelet agents. Ann Thorac Surg. 1987;43:285-287.
220. Iturbe-Alessio I, Fonseca MDC, Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med. 1986;315:1390-1393.
221. Ismail MB, Abid F, Trabelsi S, Taktak M, Fekih M. Cardiac valve prostheses, anticoagulation and pregnancy. Br Heart J. 1986;55:101-105.
222. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine. 1985;64:16-35.
223. Rogers LR, Cho ES, Kempin S, Posner JB. Cerebral infarction from nonbacterial thrombotic endocarditis: clinical and pathological study including the effects of anticoagulation. Am J Med. 1987;83:746-756.
224. Ondrias F, Slugen I, Valach A. Malignant tumors and embolizing endocarditis. Neoplasma. 1985;32:135-140.
225. Garcia I, Fainstein V, Rios A, et al. Nonbacterial thrombotic endocarditis in a male homosexual with Kaposi's sarcoma. Arch Intern Med. 1983;143:1243-1244.
226. Cammarosano C, Lewis W. Cardiac lesions in acquired immune deficiency syndrome (AIDS). J Am Coll Cardiol. 1985;5:703-706.
227. Lopez JA, Fishbein MC, Seigel RJ. Echocardiographic features of nonbacterial thrombotic endocarditis. Am J Cardiol. 1987;59:478-480.
228. Lim SP, Hakim SZ, Schoenhoff DD. Nonbacterial thrombotic endocarditis: two-dimensional echocardiographic features in an autopsy-proven case. Chest. 1987;92:176-177.
229. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17-20.
230. Webster MWI, Smith HJ, Sharpe DN, et al. Patent foramen ovale in young stroke patients. Lancet. 1988;2:11-12.
231. Lynch JJ, Schuchard GH, Gross CM, Wann LS. Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography. Am J Cardiol. 1984;53:1478-1480.
232. Biller J, Johnson MR, Adams HP, et al. Further observations on cerebral or retinal ischemia with right-left intracardiac shunts.American Medical Association. 1987;44:740-743.
233. Biller J, Adams HP, Johnson MR, Kerber RE, Toffol GJ. Paradoxical cerebral embolism: eight cases. Neurology. 1986;36:1356-1360.
234. Harvey JR, Teague SM, Anderson JL, Voyles WF, Thadani U. Clinically silent atrial septal defects with evidence of cerebral embolization. Ann Intern Med. 1986;805:695-697.
235. Lang I, Steurer G, Weissel M, Burghuber OC. Recurrent paradoxical embolism complicating severe thromboembolic pulmonary hypertension. Eur Heart J. 1988;9:678-681.
236. Higgins JR, Strunk BL, Schiller NB. Diagnosis of paradoxical embolism with contrast echocardiography. Am Heart J. 1984;107:375-377.
237. Golfus GR, Muir JJ, van Heerden JA, Harper JV. Fatal paradoxical cerebral thromboembolus. Minn Med. 1987;70:82-84.
238. Nellessen U, Daniel WG, Matheis G, Oelert H, Depping K, Lichtlen PR. Impending paradoxical embolism from atrial thrombus: correct diagnosis by transesophageal echocardiography and prevention by surgery. J Am Coll Cardiol. 1985;5:1002-1004.
239. Rosier RP, Lefer LG. Paradoxical embolism. JAMA. 1987;238:1912.
240. Loscalo J. Paradoxical embolism: clinical presentation, diagnostic strategies and therapeutic options. Am Heart J. 1986;112:141-145.
241. Perloff JK, Rosove MH, Child JS, Wright GB. Adults with cyanotic congenital heart disease: hematologic management. Ann Intern Med. 1988;109:406-413.
242. Salgado AV, Furlan AJ, Keys TF, Nichols TR, Beck GJ. Neurological complications of native and prosthetic valve endocarditis: a 12 year experience. Neurology. 1989;39:173-178.
243. Hart RG, Kagen-Hallet K, Joerns SE. Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke. 1987;18:1048-1056.
244. Salgado AV, Furlan AJ, Keys TF. Mycotic aneurysm, subarachnoid hemorrhage and indications for cerebral angiography in infective endocarditis. Stroke. 1987;18:1057-1060.
245. Davenport JG, Foster JW, Hart RG. Prosthetic valve endocarditis: antibiotics, anticoagulation and stroke. Stroke. 1988;19:145. Abstract.
246. Pruitt AA, Rubin RH, Karchmer AW, Duncan GW. Neurologic complications of bacterial endocarditis. Medicine. 1978;57:329-343.
247. Zisbrod Z, Rose DM, Jacobowitz IJ, Kramer M, Acinapura AJ, Cunningham JN. Results of open heart surgery in patients with recent cardiogenic embolic stroke and CNS dysfunction. Circulation. 1987;76(suppl 5):V109-V112.
248. Buda AJ, Zotz RJ, Le Mire MS, Buch DS. Prognostic significance of vegetations detected by two-dimensional echocardiography in infective endocarditis. Am Heart J. 1986;112:1291-1296.
249. Lutas EM, Robuls RB, Devereux RB, Prieto M. Relation between the presence of echocardiographic vegetations and the complication rate in infective endocarditis. Am Heart J. 1986;112:107-113.
250. Erbel R, Rohmann S, Drexel M, et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transesophageal approach: a prospective study. Eur Heart J. 1988;9:43-53.
251. Haft JI, Altieri J, Smith LG, Herskowitz M. Computed tomography of the abdomen in the diagnosis of splenic emboli. Arch Intern Med. 1988;148:193-197.
252. LeCam B, Guivarch G, Boles JM, Garre M, Cartier F. Neurologic complications in a group of 86 bacterial endocarditis. Eur Heart J. 1984;5(suppl C):97-100.
253. Bamford J, Hodges J, Warlow C. Late rupture of a mycotic aneurysm after cure of bacterial endocarditis. J Neurol. 1986;233:51-53.
254. Holtzman RNN, Taylor-Dickinson PC, Hughes JEO, Brust JCM. Cerebral mycotic aneurysms: presentation and outcome. Ann Neurol. 1988;24:129.
255. Morawetz RB, Karp RB. Evolution and resolution of intracranial bacterial (mycotic) aneurysms. Neurosurgery. 1984;15:43-49.
256. Keyser DL, Biller J, Coffman TJ, Adams HP. Neurological complications of prosthetic valve endocarditis. Ann Neurol. 1988;24:130. Abstract.
257. Leport C, Vilde JL, Bricaire F, et al. Fifty cases of late prosthetic valve endocarditis: improvement in prognosis over a 15-yr period. Br Heart J. 1987;58:66-71.
258. Wilson WR, Geraci JE, Danielson GK, et al. Anticoagulant therapy and central nervous system complications in patients with prosthetic valve endocarditis. Circulation. 1978;57:1004-1007.
259. Wilson WR, Danielson GK, Giuliani ER, Geraci JE. Prosthetic valve endocarditis. Mayo Clin Proc. 1982;57:155-161.
260. Jespersen CM, Egeblad H. Mitral annulus calcification and embolism. Acta Med Scand. 1987;222:37-41.
261. Levine JH, Pauker S, Saltzman EW. Antithrombotic therapy in valvular heart disease. Chest. 1989;95(suppl):98-106.
262. Ramsdale DR, Arumugam N, Singh SS, Pearson J, Charles RG. Holter monitoring in patients with mitral stenosis and sinus rhythm. Eur Heart J. 1987;8:164-170.
263. Daniel WG, Nellessen U, Schroder W, et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol. 1988;11:1204-1211.
264. Seigel R, Tresch DD, Keelan MH, Brooks HL. Effects of anticoagulation δn recurrent systemic emboli in mitral stenosis. Am J Cardiol. 1987;60:1191-1192.
265. Furlan AJ, Craciun AR, Raju NR, Hart N. Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis. Stroke. 1984;15:282-284.
266. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation. 1976;53:273-279.
267. Koga Y, Itaya K, Toshima H. Prognosis in hypertrophic cardiomyopathy. Am Heart J. 1984;108:351-355.
268. Lombard JT, Selzer A. Valvular aortic stenosis. Ann Intern Med. 1987;106:292-298.
269. Davidson CJ, Skelton TN, Kisslo KB, et al. The risk of systemic embolization associated with percutaneous balloon valvuloplasty in adults. Ann Intern Med. 1988;108:557-560.
270. Safian RD, Berman AD, Diver DJ, et al. Balloon aortic valvuloplasty in 170 consecutive patients. N Engl J Med. 1988;319:125-130.
271. Belkin RN, Hurwitz BJ, Kisslo KB. Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. Stroke. 1987;18:856-862.
272. Gallet B, Malergue MC, Adams C, et al. Atrial septal aneurysm: potential cause of systemic embolism: an echocardiographic study. Br Heart J. 1985;53:292-297.
273. Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol. 1985;6:1370-1382.
274. Di Pasquale G, Andreoli A, Grazi P, Dominici P, Pinelli G. Cardioembolic stroke from atrial septal aneurysm. Stroke. 1988;19:640-643.
275. Roberts WC. Aneurysm (redundancy) of the atrial septum (fossa ovale membrane) and prolapse (redundancy) of the mitral valve. Am J Cardiol. 1984;54:1153-1154.
276. Silver MD, Dorsey JS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med. 1978;102:62-65.
277. Markel ML, Waller BF, Armstrong WF. Cardiac myxoma: a review. Medicine. 1987;66:114-126.
278. Hart RG, Miller VT. Cerebral infarction in young adults: a practical approach. Stroke. 1983;14:110-114.
279. Knepper LE, Biller J, Adams HP, Bruno A. Neurologic manifestations of atrial myxoma. Stroke. 1988;19:1435-1440.
280. Kasarskis EJ, O'Connor W, Earle G. Embolic stroke from cardiac papillary fibroelastomas. Stroke. 1988;19:1171-1173.
281. Limper AH, Prakash UBS, Kokemen E, Callahan MJ. Cardiopulmonary metastatic lesions of osteosarcoma and associated cerebral infarction. Mayo Clin Proc. 1988;63:592-595.
282. Chalmers N, Campbell IW. Left atrial metastasis presenting as recurrent embolic strokes. Br Heart J. 1987;58:170-172.
283. Hirsh J. Is the dose of warfarin prescribed by American physicians unnecessarily high? Arch Intern Med. 1987;147:769-771.
284. Hull R, Hirsh J, Jay R, et al. Different intensities of anticoagulation in the long term treatment of proximal venous thrombosis. N Engl J Med. 1982;307:1676-1681.
285. Poller L, McKernan A, Thompson JM, Elstein M, Hirsh PJ, Jones JB. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Br Med J Clin Res. 1987;295:1309-1312.
286. Yatsu FM, Hart RG, Mohr JP, Grotta JC. Anticoagulation of embolic strokes of cardiac origin: an update. Neurology. 1988;38:314-316.
287. Cerebral Embolism Study Group. Cardioembolic stroke, immediate anticoagulation and brain hemorrhage. Arch Intern Med. 1987;147:636-640.
288. Laureno R, Shields RW, Narayan T. The diagnosis and management of cerebral embolism and hemorrhagic infarction with sequential computerized cranial tomography. Brain. 1987;110:93-105.
289. Rothrock JR, Lyden PD, Taft BJ. Acute anticoagulation of cardioembolic stroke and TIA. Stroke. In press.
290. Sage JI. Prospective study of stroke associated with nonvalvular atrial fibrillation: low frequency of early recurrence. Ann Neurol. 1986;20:155. Abstract.
291. Gustafsson C, Britton M. Prognosis after brain infarction in patients with nonvalvular atrial fibrillation compared with sinus rhythm. Acta Neurol Scand. 1986;73:520. Abstract.
292. Sato Y, Mizoguchi K, Sato Y, Ohkita Y, Masaro K. Anticoagulant and thrombolytic therapy for cerebral embolism of cardiac origin. Kurume Med J. 1986;33:89-95.
293. Fisher CM. Embolism in atrial fibrillation. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial Fibrillation. Molndal, Sweden: AB Hassle; 1982:192-205.
294. Hart RG, Coull BM, Hart PD. Early recurrent embolism associated with nonvalvular atrial fibrillation. Stroke. 1983;14:688-693.
295. Santamaria J, Graus F, Peres J. Cerebral embolism and anticoagulation. Neurology. 1983;33:1104.
296. Kelley RE, Berger JR, Alter M, Kovacs AG. Cerebral ischemia and atrial fibrillation. Neurology. 1985;35:938-939.
297. Gorsselink EL, Lodder J, van der Lugt PJM. Risk of early anticoagulation in patients with small deep infarcts possibly caused by cardiogenic emboli. Clin Neurol Neurosurg. 1987;89:157-159.
298. Krijne-Kubat B, Lodder J, van der Lugt PJM. Hemorrhagic infarction on CT in cardioembolic stroke. Clin Neurol Neurosurg. 1987;89:103-105.
299. Lodder J, Kubat-Krijne B, van der Lugt PJM. Timing of autopsy-confirmed hemorrhagic infarction with reference to cardioembolic stroke. Stroke. 1988:19:1482-1484.
300. Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke. 1988;19:802-812.
301. Brucher JM, DeSmet YD, Gonsette RE. Rupture of the arterial wall in two cases of recent cerebral embolism: morphological expression of cerebral vasospasm? J Neurol. 1986;233:267-270.
302. Hecht-Leavitt C, Gomori JM, Grossman RI, et al. High-field MRI of hemorrhagic cortical infarction. Am J Neuroradiol. 1986;7:581-585.
303. Salgado ED, Weinstein M, Furlan AJ, et al. Proton magnetic resonance imaging in ischemic cerebrovascular disease. Ann Neurol. 1986;20:502-507.